PubMed:7903907 / 0-139 JSONTXT

{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":89,"end":98},"obj":"gene:2064"},{"id":"T1","span":{"begin":125,"end":138},"obj":"disease:C0678222"},{"id":"T2","span":{"begin":89,"end":98},"obj":"gene:2064"},{"id":"T3","span":{"begin":125,"end":138},"obj":"disease:C0006142"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer."}

{"project":"jnlpba-st-training","denotations":[{"id":"T1","span":{"begin":89,"end":107},"obj":"DNA"}],"text":"Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer."}

{"project":"pubmed-sentences-benchmark","denotations":[{"id":"S1","span":{"begin":0,"end":139},"obj":"Sentence"}],"text":"Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer."}

{"project":"genia-medco-coref","denotations":[{"id":"C1","span":{"begin":10,"end":38},"obj":"NP"},{"id":"C4","span":{"begin":111,"end":138},"obj":"NP"},{"id":"C3","span":{"begin":85,"end":138},"obj":"NP"},{"id":"C2","span":{"begin":55,"end":138},"obj":"NP"}],"text":"Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer."}

{"project":"GENIAcorpus","denotations":[{"id":"T1","span":{"begin":10,"end":38},"obj":"other_name"},{"id":"T2","span":{"begin":89,"end":107},"obj":"DNA_domain_or_region"},{"id":"T3","span":{"begin":111,"end":119},"obj":"multi_cell"},{"id":"T4","span":{"begin":125,"end":138},"obj":"other_name"}],"text":"Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer."}